Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M102334200 on August 10, 2001

J. Biol. Chem., Vol. 276, Issue 43, 39695-39704, October 26, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/43/39695    most recent
M102334200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cano-Abad, M. F.
Right arrow Articles by López, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cano-Abad, M. F.
Right arrow Articles by López, M. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Calcium Entry through L-type Calcium Channels Causes Mitochondrial Disruption and Chromaffin Cell Death*

María F. Cano-AbadDagger §, Mercedes VillarroyaDagger , Antonio G. GarcíaDagger ||**, Nelson H. GabilanDagger Dagger , and Manuela G. LópezDagger §§

From the Dagger  Instituto de Farmacología Teófilo Hernando, Departamento de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, Madrid 28029, Spain, || Servicio de Farmacología Clínica, Hospital de la Princesa, C/Diego de León 62, Madrid 28006, Spain, ** Instituto Universitario de Investigaciones Gerontológicas y Metabólicas, Hospital de la Princesa, C/Diego de León 62, Madrid 28006, Spain, and Dagger Dagger  Departamento de Bioquímica, Universidad Federal de Santa Catarina, Florianópolis 88049SC, Brasil

Received for publication, March 15, 2001, and in revised form, July 5, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Sustained, mild K+ depolarization caused bovine chromaffin cell death through a Ca2+-dependent mechanism. During depolarization, Ca2+ entered preferentially through L-channels to induce necrotic or apoptotic cell death, depending on the duration of the cytosolic Ca2+ concentration ([Ca2+]c) signal, as proven by the following. (i) The L-type Ca2+ channel activators Bay K 8644 and FPL64176, more than doubled the cytotoxic effects of 30 mM K+; (ii) the L-type Ca2+ channel blocker nimodipine suppressed the cytotoxic effects of K+ alone or K+ plus FPL64176; (iii) the potentiation by FPL64176 of the K+-evoked [Ca2+]c elevation was totally suppressed by nimodipine. Cell exposure to K+ plus the L-type calcium channel agonist FPL64176 caused an initial peak rise followed by a sustained elevation of the [Ca2+]c that, in turn, increased [Ca2+]m and caused mitochondrial membrane depolarization. Cyclosporin A, a blocker of the mitochondrial transition pore, and superoxide dismutase prevented the apoptotic cell death induced by Ca2+ overload through L-channels. These results suggest that Ca2+ entry through L-channels causes both calcium overload and mitochondrial disruption that will lead to the release of mediators responsible for the activation of the apoptotic cascade and cell death. This predominant role of L-type Ca2+ channels is not shared by other subtypes of high threshold voltage-dependent neuronal Ca2+ channels (i.e. N, P/Q) expressed by bovine chromaffin cells.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Alteration of calcium homeostasis is hypothesized to contribute to neuronal death following ischemia-reperfusion (1-5) or neurodegenerative diseases like Alzheimer's disease (6-11). An overload of neuronal Ca2+ may activate a number of pathological processes like disruption of the mitochondrial membrane potential, free radical production, stimulation of catabolic enzymes, and enhancement of excitatory amino acid release that will lead to cell death (12). Considerable attention has been focused on the possibility of Ca2+ entry through the N-methyl-D-aspartate-glutamate receptor gated channel as responsible for Ca2+ overload, but other sources are also being considered, such as release from intracellular stores or Ca2+ influx through high threshold voltage-dependent calcium channels (VDCC)1 (4, 13-15).

In neurons, several subtypes of high threshold and low threshold VDCC (L-, N-, P/Q-, R-, and T-type) have been described (16-18). These channels have different voltage sensitivities, kinetic properties, and pharmacological profiles (16-19). L-type VDCC have been localized predominantly in the soma and proximal dendrites of neurons throughout the brain (19-21) and are sensitive to dihydropyridine activators (e.g. Bay K 8644) and blockers (e.g. nimodipine).

At the moment, there are enough pieces of evidence that support the participation of Ca2+ entry through L-channels during ischemia, to cause cell death (13, 14, 21-24). However, the mechanism by which cell death is orchestrated by such Ca2+ entry has not been defined precisely. In this work, we attempt to clarify such a mechanism using the bovine adrenal medullary chromaffin cell as a model. This cell expresses the same set of Ca2+ channel subtypes described in neurons (25). Bovine chromaffin cells in primary cultures constitute a homogeneous cell population that expresses various subtypes of Ca2+ channels at relative densities similar to certain types of neurons (i.e. granular cerebellar neurons (about 20% L-type, 30% N-type, and 50% P/Q-type) (26)). In addition, R-type channels have been recently discovered in chromaffin cells using the perforated configuration of the patch-clamp technique (27). Hence, bovine chromaffin cells constitute an adequate model to investigate the problem posed here (i.e. (i) to know whether Ca2+ entry through these channels during sustained depolarization produced apoptotic cell death; (ii) to define why the L-channel pathway is more efficacious to activate this lethal signal; and (iii) to determine which is the role of mitochondria in the activation of cell death.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials and Solutions-- Dulbecco's modified Eagle's medium and fetal calf serum were obtained from Life Technologies, Inc.; nimodipine, FPL64176, Bay K 8644, and superoxide dismutase (SOD) were from Sigma; omega -conotoxin GVIA was from Bachem Feinchemikalien (Switzerland); and omega -conotoxin MVIIC and omega -agatoxin IVA were from the Peptide Institute (Osaka, Japan). The assay kit for measuring the activity of lactate dehydrogenase (LDH) and Cell Death Detection Elisaplus Kit were purchased from Roche Molecular Biochemicals. Fura-2/AM, rhodamine 123, Vybrant Apoptosis Kit, and Mitotracker Red were purchased from Molecular Probes, Inc.

Concentrated solutions of drugs were prepared in water (omega -conotoxin GVIA, omega -conotoxin MVIIC, omega -agatoxin IVA, superoxide dismutase), dimethyl sulfoxide (nimodipine, FPL64176), or ethanol (Bay K 8644). Appropriate dilutions were then made in Krebs-Hepes solution containing 144 mM NaCl, 5.9 mM KCl, 1.2 mM MgCl2, 2 mM CaCl2, 10 mM Hepes, 11 mM glucose, pH 7.3, titrated with NaOH. Me2SO, at the final concentration used (less than 0.1%), had no effect on any of the parameters tested.

Preparation and Culture of Bovine Chromaffin Cells-- Bovine adrenal medullary chromaffin cells were isolated as previously described (28) with some modifications (29). To reduce the number of endothelial cells in the culture that could alter LDH measurements, cells were preplated for 30 min, and proliferation inhibitors (cytosine arabinoside, L-leucine methyl esther, and fluorodeoxyuridine) were used during the maintenance of the culture in the Dulbecco's modified Eagle's medium. For cell death studies, cells were plated at a density of 5 × 105 cells/well on 24-well Orange plates coated with 0.01 mg ml-1 of poly-L-lysine, containing 1 ml of Dulbecco's modified Eagle's medium supplemented with 5% fetal calf serum, 10 µM cytosine arabinoside, 10 µM fluorodeoxyuridine, 10 µM leucine methyl esther, 50 IU ml-1 penicillin, and 50 µg ml-1 streptomycin. Cultures were maintained for 2-3 days at 37 °C in a water-saturated atmosphere with 5% CO2. After 24 h, the medium was replaced by 1 ml of serum-free fresh medium and subsequently changed every 2-3 days. Cells were normally used during days 2-3, to avoid excessive growth of endothelial cells that could interfere with LDH measurements.

LDH Assay-- Extracellular and intracellular LDH activities were spectrophotometrically measured by following tetrazolium reduction at an absorbance wavelength of 492 nm. Total LDH activity was defined as the sum of intracellular plus extracellular LDH activity. Released LDH was defined as the percentage of extracellular compared with total LDH activity (30).

Nuclear Staining of DNA-- For microscopic nuclear DNA analysis, bovine chromaffin cells cultured in 24-well plates (5 × 105/well) were stained with 5 µg/ml Hoechst dye 33342 in Krebs-Hepes solution for 30 min at 37 °C (31). Stained cells were washed twice with phosphate-buffered saline, removed from the well by gentle shaking, and placed in a plastic tube for centrifugation at 800 rpm for 10 min. Supernatants were removed, and cells were resuspended in 50 µl of phosphate-buffered saline. A sample of 15 µl of the stained cells was placed on a coverslip and counted under the fluorescent microscope. Fluorescence microscopy was performed using a Nikon Elipse TE300 microscope, using the appropriate filter for an excitation wavelength of 355 nm and an emission wavelength of 465 nm. Nuclei with the apoptotic features were counted as apoptotic cells of a total of 300 cells in at least three different batches of cells. The percentage was calculated for each sample.

DNA Fragmentation Analysis-- For the quantitative determination of cytoplasmic histone-associated DNA fragments, the Cell Death Detection Elisaplus Kit was used (32). After induction of cell death, every well was treated with the lysis buffer for 30 min. Samples were spun down at 200 × g for 10 min. An aliquot from the supernatant (20 µl) was transferred to the streptavidin-coated microplate for analysis. 80 µl of the immunoreagent mixture prepared with <FR><NU>1</NU><DE>20</DE></FR> volume of anti-DNA-peroxidase and <FR><NU>1</NU><DE>20</DE></FR> volume of anti-histone-biotin with <FR><NU>18</NU><DE>20</DE></FR> volumes of incubation buffer were added to each well and maintained for 2 h at room temperature with gentle shaking. Thereafter, the solution was removed by aspiration, and the wells were rinsed three times with 250 µl of incubation buffer. Then 100 µl of the substrate solution was added to each well and incubated for 5 min until the color developed. Measurements were made at 600 nm. Results were expressed as the absorbance of each sample and compared with basal levels.

Measurement of Cytosolic Ca2+ Concentrations, [Ca2+]c-- For these experiments, cells were plated on 1-cm diameter glass coverslips at a density of 5 × 104 cells/coverslip. Cells were loaded with Fura-2/AM (4 µM) for 45 min at 37 °C in Krebs-Hepes solution. Loading with the fluorescent dye was terminated by washing the coverslip containing the attached cells twice with Krebs-Hepes; then the cells were kept at room temperature for 15 min before placing them in the headstage of a Nikon Diaphot microscope to measure their fluorescence.

The fluorescence of Fura-2 in single cells was measured with the photomultiplier-based system (33), which produces a spatially averaged measurement of the [Ca2+]c. Fura-2 was excited with light alternating between 360 and 390 nm, using a Nikon × 40 fluorite objective. Emitted light was transmitted through a 425-nm dichroic mirror and 500-545-nm barrier filter before being detected by the photomultiplier. [Ca2+]c was calculated from the ratios of the light emitted when the dye was excited by the two alternating excitation wavelengths (34).

Measurements of Mitochondrial Transmembrane Potential (Delta Psi m) by Fluorescence Confocal Imaging-- The fluorescence of rhodamine 123 was used to measure Delta Psi m (35). Cells were incubated for 30 min in the presence of 10 µM of the dye. Rhodamine 123 was added to all of the solutions used during the experiment, in order to avoid washout of the dye. Three to six cells were studied in each experiment. Images were collected at 1 image/0.372 s. Cellular fluorescence was imaged using a MRC 6000 confocal laser-scanning microscope with excitation at 488 nm and emission at 510 nm and a × 60 oil immersion objective. Pixel intensity/cell was determined using Bio-Rad software. Base-line fluorescence (Fo) was measured as normalized fluorescence emitted during the experiment. Increments in fluorescence indicate mitochondrial depolarization. All experiments were performed at 22 ± 1 °C in bovine chromaffin cells cultured for 2-3 days.

Mitotracker Red to Visualize Mitochondria-- Cells were placed in coverslips at a density of 3 × 105 cells. Control and treated cells (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+) were loaded with the cell-permeant mitochondrial dye, Mitotracker red 100 nM at 37 °C for 30 min. Once the Mitotracker probe accumulates in mitochondria, it reacts with accessible thiol groups of peptides and proteins and forms an aldehyde conjugate that is stable. Fluorescent images were taken under a confocal laser-scanning microscope with excitation at 570 nm and emission at 599 nm (36, 37).

Statistical Analysis-- Data were expressed as means ± S.E. Statistical significance of differences between means was determined by an analysis of variance test. If significant differences were found, an appropriate multiple comparison test (Fisher PLSD) was done. In some cases, Student's t test was used (see Figs. 1 and 3-6 legends). Differences were considered significant at the level of p < 0.05.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Cell Death as a Function of Depolarization and Ca2+ Entry through L-type Calcium Channels: Protection by Nimodipine-- To facilitate ionic manipulations, all experiments were performed in Krebs-Hepes solutions. For instance, in the experiment shown in Fig. 1a, cells were incubated in Krebs-Hepes solution containing increasing concentrations of KCl (5.9-50 mM), with isosmotic reduction of NaCl, for 24 h at 37 °C. At the end of this incubation period, the medium was collected to measure LDH released from dead cells (extracellular LDH; LDHe); the cells that remained attached to the well were then lysed, and their LDH content was measured. The expression of LDHe as a percentage of total LDH provides an indication of the fraction of cells dying as a consequence of a given treatment, in this case depolarization of increasing strengths. Incubation of the cells for 24 h with increasing [K+]e gave a gradual release of LDHe; maximum cell damage was observed at 30 mM K+, which caused 25% cell loss; a further increase to 50 mM K+ did not enhance cell death. Hence, 30 mM [K+]e was chosen to perform subsequent experiments.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 1.   Cell death induced by Ca2+ entry through L-channels depends on [Ca2+]e: Nimodipine provides total cytoprotection. a, cell death expressed as a percentage of LDH released to the external medium in chromaffin cells incubated for 24 h with increasing concentrations of [K+]e in the presence of 2 mM Ca2+. Basal release refers to cells treated with a control Krebs-Hepes solution containing 5.9 mM K+ and 2 mM Ca2+. b, the [Ca2+]e dependence of the cell damage induced by depolarization of the cells with 30 mM K+ during 24 h. c, dose-response curves of different L-type Ca2+ channel agonists in 30 mM K+ and 2 mM Ca2+. d, total cytoprotection afforded by 1 µM nimodipine in the presence of 0.3 µM FPL64176/30 mM K+ at increasing [Ca2+]e. The combination of toxins (1 µM MVIIC, 1 µM GVIA, and 1 µM Aga IVA) to block N/P/Q-type Ca2+ channels in the presence of 0.3 µM of FPL64176 and 30 mM K+ afforded a cytoprotectant effect at low [Ca2+]e (0.2, 0.5, and 2 mM) but not at high [Ca2+]e (5, 10, and 20 mM). Data are the mean ± S.E. of 9-12 wells from three different batches of cells. ***, p < 0.001; *, p < 0.05 with respect to basal release (analysis of variance test).

Cell damage was not only a function of the degree of VDCC opened upon depolarization with high [K+]e but also of the quantity of external Ca2+ offered to the cells ([Ca2+]e). In a second experiment (Fig. 1b), the effects of increasing [Ca2+]e on cell death, at a fixed level of depolarization (30 mM K+), were assayed. Cell death after a 24-h incubation was close to basal at 0.2-0.5 mM [Ca2+]e (13% LDHe release); at 2-10 mM [Ca2+]e, cell death increased to around 25%, and it declined to 20% at 20 mM [Ca2+]e; this effect could be due to inactivation by excess Ca2+ of VDCC (38-40).

To increase the cell damage caused by Ca2+ entry through L-type VDCC, we used different L-type agonists like FPL64176, (+)Bay K 8644, and (-)Bay K 8644 (41) under mild depolarizing conditions (30 mM [K+]e) for 24 h. Fig. 1c shows the cytotoxic consequence of the incubation with these agonists at concentrations that ranged from 0.3 to 10 µM. Maximum cytotoxic effects, for all drugs tested, were observed at 0.3-1 µM; higher concentrations of the agonists (3-10 µM) presented a decrease in LDHe; this effect can be explained by their Ca2+ antagonist action at high concentrations (41, 42). Out of the three L-type agonists used, FPL64176 presented the highest cytotoxic effects. Therefore, the combination of 0.3 µM FPL64176 in 30 mM [K+]e was used to induce cell death via Ca2+ entry through L-type VDCC.

The cytotoxic effect of Ca2+ entry through L-channels induced by FPL64176 was dependent on the [Ca2+]e. In Fig. 1d, basal LDHe (24-h incubation in 5.9 mM K+) amounted to 8.4 ± 0.9%; 0.3 µM FPL64176 in the presence of 30 mM K+ increased the basal LDHe at all [Ca2+]e studied. For instance, at 0.2 mM [Ca2+]e, LDHe increased from 12.3 ± 2.6% (Fig. 1b) to 25.9 ± 2.6% in the presence of FPL. Maximum cell death was achieved in the presence of 5-10 mM [Ca2+]e (41.5 ± 2.0 and 43.5 ± 1.8%, respectively). It is interesting that this sharp increase in cell death could be completely reversed by a 1 µM concentration of the L-type Ca2+ channel blocker nimodipine (Fig. 1d); LDHe after 24 h was in the range of 10-15% (i.e. similar to that found in basal conditions (5.9 mM K+)). It is worth noting that nimodipine counteracted both the LDHe increase evoked by 30 mM K+ in the absence (about 25%) and in the presence of FPL64176 (about 50%), suggesting that the increase in cell death was associated to increased Ca2+ entry mostly through L-type Ca2+ channels.

[Ca2+]c Signals and Cell Damage Generated by K+ at Low and High [Ca2+]e: Effects of FPL64176-- Since cell damage caused by depolarization was minimum at 0.2 mM [Ca2+]e and maximum at 5 mM [Ca2+]e, we selected these extreme [Ca2+]e values to analyze the time course of the [Ca2+]c signals in Fura-2-loaded single cells exposed to 30 mM K+. Cells superfused with 0.2 mM [Ca2+]e gave an average initial basal [Ca2+]c of 55 ± 4.8 nM. Exposure to 30 mM K+, 0.2 mM Ca2+ caused an initial mean peak of 198 ± 39 nM (n = 8) (Fig. 3a). Despite the sustained depolarization with K+, the [Ca2+]c peak declined quickly to basal levels and remained stable along the rest of the 30-min period of recording. In 5 mM [Ca2+]e, the resting [Ca2+]c was 61 ± 5.9 nM (n = 7); upon superfusion with 30 mM K+, 0.2 mM Ca2+, an initial [Ca2+]c peak of 560 ± 45 nM was reached (n = 7); then the peak [Ca2+]c declined gradually and reached a stable plateau of 242 ± 79 nM.

The transient nature of the [Ca2+]c signal was probably due to voltage- and [Ca2+]c-dependent inactivation of Ca2+ channels upon sustained cell depolarization (38-40). This transient response of [Ca2+]c might explain the scarce cell damage observed in the experiments of Fig. 1b. Hence, we tried to delay the inactivation of Ca2+ channels by using the L-type Ca2+ channel activator FPL64176. In the presence of 0.3 µM FPL64176, 30 mM K+, 0.2 mM Ca2+, the initial peak of [Ca2+]c reached 432 ± 130 nM (n = 4) and then declined to reach a stable Ca2+ entry of 299 ± 8 nM. Thus, FPL64176 converted the [Ca2+]c signal obtained in 0.2 mM [Ca2+]e into a response similar to that produced by 5 mM [Ca2+]e. When FPL64176 was applied in the presence of high [Ca2+]e (5 mM), the [Ca2+]c rose initially to a peak of 905 ± 120 nM (n = 9) and then declined to a sustained plateau that was 1.4-fold higher (409 ± 91 nM) than in low [Ca2+]e (0.2 mM), along the rest of the 30-min depolarization period (Fig. 2d).


View larger version (20K):
[in this window]
[in a new window]
 
Fig. 2.   FPL64176 increases by 2-fold the [Ca2+]c induced by 30 mM K+ at low (0.2 mM) and high (5 mM) [Ca2+]e. Shown are original traces of single cell [Ca2+]c measurements in Fura-2-loaded cells. The cell being explored was continuously superfused with Krebs-Hepes solution containing 0.2 mM (a and c) or 5 mM (b and d) [Ca2+]e. The potentiating effect of FPL64176 (0.3 µM) on the [Ca2+]c signals can be observed in c and d at 0.2 and 5 mM [Ca2+]e, respectively.

When measuring the total quantity of Ca2+ entering the cells during the 30-min exposure period in low (0.2 mM) or high (5 mM) [Ca2+]e in the presence or absence of FPL64176, we observed that the maximum levels of [Ca2+]c were achieved when using 5 mM [Ca2+]e plus FPL64176 (496 ± 77 nM·s) (n = 8). Ca2+ entry at 0.2 mM [Ca2+]e plus FPL64176 and 5 mM [Ca2+]e alone were rather similar, 317 ± 8 nM·s (n = 4) and 302 ± 62 nM·s (n = 8), respectively. The same pattern was also observed when measuring the initial peak of [Ca2+]c (see Fig. 3a).


View larger version (23K):
[in this window]
[in a new window]
 
Fig. 3.   Cell death as a function of [Ca2+]c. a, the average Ca2+ entry into the cell during a 30-min period, in terms of area under the curve of [Ca2+]c (nM·s) and maximum peak (nM) reached with a mild depolarization with 30 mM [K+]e in low (0.2 mM) or high (5 mM) [Ca2+]e and in the presence or absence of the L-type Ca2+ channel activator, FPL64176 (0.3 µM). Total Ca2+ entry ranged from 200 nM·s at low (0.2 mM) [Ca2+]e without FPL64176 to 500 nM·s at high (5 mM) [Ca2+]e in the presence of FPL64176. *, p < 0.05; **, p < 0.01 with respect to 0.2 mM Ca2+ or 5 mM Ca2+ in the absence of FPL64176 (Student's t test). b shows the correlation between total Ca2+ entry (nM·s) and cell death expressed as LDHe release (% total). Maximum cell death was reached at 5 mM [Ca2+]e, 30 mM K+, and 0.3 µM FPL64176. Data are the mean ± S.E. of 8-10 cells from three different batches of cells.

When analyzing cell lesions as LDHe released, we observed that the amount of Ca2+ entering the cell during 30 min, measured as the integral of the curve of [Ca2+]c, correlated well with the extent of cell death observed 24 h later (see Fig. 3b). These results prove that cell lesion is a function of the quantity of Ca2+ entering through VDCC and that it depends not only on the [Ca2+]e but also on the inactivation state of those channels.

Cytoprotection Afforded by Nimodipine Is Related to the Reduction of [Ca2+]c-- We had previously observed (Fig. 1d) that 1 µM nimodipine completely counteracted LDH release induced by Ca2+ overload through L-type Ca2+ channels. In order to determine if the protection afforded by nimodipine was related to a reduction in the levels of [Ca2+]c, we performed experiments in single Fura-2/AM-loaded cells. Fig. 4 shows how nimodipine restored the [Ca2+]c to basal levels after the [Ca2+]c was raised by FPL64176, 30 mM K+, both at low (0.2 mM), (Fig. 4a) and high (5 mM) (Fig. 4b) [Ca2+]e. Total Ca2+ entry, analyzed as the area under the curve, in the presence and absence of nimodipine was significantly reduced from 80 ± 8 µM·s to 10 ± 1 µM·s (n = 5) at 0.2 mM [Ca2+]e and from 120 ± 12 µM·s to 15 ± 1 µM·s (n = 5) at 5 mM [Ca2+]e (Fig. 4c). This drastic reduction in the [Ca2+]c could explain the total cytoprotection observed previously with nimodipine (see Fig. 1d).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 4.   Nimodipine returned to basal levels the [Ca2+]c rise induced by FPL64176. In single Fura-2-loaded cells stimulated with 0.3 µM FPL64176, 30 mM K+, nimodipine (1 µM) reduced the [Ca2+]c to basal levels (a); this effect was reversible (b). c represents total mean Ca2+ entry obtained during 5 min with 0.3 µM FPL64176/30 mM K+ at low (0.2 mM) or high (5 mM) [Ca2+]e, alone or in the presence of nimodipine. ***, p < 0.001 with respect to the depolarizing pulse in the absence of nimodipine (Student's t test).

Since nimodipine is selectively blocking L-type Ca2+ channels, it seemed obvious that N- and P/Q-type Ca2+ channels would not be contributing to the Ca2+ signals or to the LDHe release in cells exposed to Ca2+ overload through L-channels. This possibility was verified by measuring both [Ca2+]c changes and cell death in the presence of non-L-type Ca2+ channel blockers (omega -conotoxin GVIA for N-channels plus omega -conotoxin MVIIC for N/P/Q-channels). When measuring cell damage as a function of LDH release in depolarized cells treated with FPL64176 at different [Ca2+]e (0.2-20 mM), we curiously observed significant cytoprotection by N/P/Q-type blockers at low [Ca2+]e (0.2-2 mM) but not at higher concentrations (i.e. above 5 mM; see Fig. 1d). However, the increase of [Ca2+]c induced by FPL64176, 30 mM K+ in low and high [Ca2+]e was not significantly modified in the presence of the non-L-type channel blockers (data not shown).

Prolonged Ca2+ Entry through L-type Channels Leads Primarily to Necrotic Cell Death-- To further understand the basic mechanism by which chromaffin cells were dying upon their sustained depolarization, we compared the amount of necrosis measured as LDH release and apoptosis measured as histone-associated DNA fragments in cells exposed for 24 h to FPL64176, 30 mM K+, 5 mM Ca2+. Fig. 5a shows that the cytotoxic effect of Ca2+ entry through L-channels induced significant LDHe release but no significant increase in the number of apoptotic cells. These results suggest that the elevation of [Ca2+]c during prolonged depolarizations, in the presence of an L-type channel activator, constitutes predominantly a necrotic signal.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 5.   Sustained Ca2+ overload through L-channels mediates necrotic cell death. a, cell death measured as apoptosis (black columns) or necrosis (white columns), at low (0.2 mM) or high (5 mM) [Ca2+]e in the presence of the depolarizing mixture (0.3 µM FPL64176/30 mM K+) for 24 h. Data correspond to the mean + S.E. of four experiments from three different batches of cells. Statistical differences were observed among the LDHe measurements but not for the apoptotic measurements. **, p < 0.01 with respect to basal level (Student's t test). Shown are mitochondria stained with the fluorescent dye Mitotracker red, in a resting cell (b) and in a cell exposed to calcium overload through L-channels (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+) (c).

During cell necrosis, dramatic changes can be observed in the mitochondrial structure (9). The morphological changes in the mitochondria network induced by prolonged (24-h) Ca2+ entry through L-channels could be observed in cells stained with the mitochondrial dye Mitotracker red. Chronic treatment with FPL64176 induced total disruption of the mitochondrial mesh (Fig. 5c), indicating cell necrosis. In contrast, the control cell in Fig. 5b presents the mitochondrial network completely preserved.

Transient Ca2+ Overload through L-channels Mediates Apoptotic Cell Death Secondary to the Release of Cytochrome c and Free Radicals from the Mitochondria-- During an ischemic episode, a transient lack of oxygen normally occurs. Therefore, we tried experimental conditions where Ca2+ overload through L-channels (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+) had a duration of 30 min; we evaluated the cytotoxic consequence of such stimulus, measuring cell death as release of LDH (immediately after the stimulus) and the number of apoptotic nuclei (48 h after the stimulus) with the fluorescent dye Hoechst. We found that Ca2+ entering through L-channels for 30 min almost doubled the basal release of LDH and increased the number of apoptotic nuclei from 11 ± 0.7% (basal) to 26.8 ± 3.3% (depolarizing pulse) after 48 h (Fig. 6a). These results contrast with those obtained when the toxic stimulus (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+) was kept for 24 h (Fig. 5). In the latter case, no significant increase in the number of apoptotic nuclei was observed; the main lesion found was necrotic. These results indicated that shorter increases in the [Ca2+]c were capable of activating the apoptotic cascade; the question now was to verify how this mechanism was taking place.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 6.   Transient Ca2+ entry through L-channels mediates necrotic and apoptotic cell death. A depolarizing period of 30 min (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+) induced significant increase in the percentage of apoptotic nuclei measured with the fluorescent dye Hoechst 48 h later (a) and necrotic cell death measured as percentage of LDHe immediately after the cytotoxic pulse (b). SOD (1500 units), nimodipine (1 µM), and CsA (3 µM), during the 30-min depolarization period, prevented the delayed apoptotic cell death (a). Early necrotic cell death, measured as LDHe, was prevented by nimodipine and SOD but not by CsA (b). Data correspond to the mean ± S.E. of three experiments from three different batches of cells. *, p < 0.05; ***, p < 0.001 with respect to 0.3 µM FPL64176, 30 mM K+ (Student's t test).

Transient peaks in [Ca2+]c can secondarily increase mitochondrial Ca2+ ([Ca2+]m), lead to the opening of the mitochondrial transition pore (43), release of cytochrome c (36) with the resultant release of oxygen free radicals (like superoxide) from the electron transport chain (44, 45), and initiate the apoptotic cascade (46). To determine if the cells were dying through this mechanism, we performed two types of experiments: (i) blockade of the opening of the transition pore by CsA (3 µM) and the subsequent release of cytochrome c and (ii) use of the antioxidant enzyme SOD to prevent the action of superoxide free radicals that could be released from mitochondria. When CsA and SOD were present during the 30-min depolarizing pulse (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+), the number of apoptotic nuclei returned to basal levels (10.8 ± 2.3 and 7.5 ± 2.4%, respectively), indicating that release of cytochrome c and free radicals was involved in inducing apoptosis via Ca2+ entry through L-channels. When Ca2+ entry was prevented with nimodipine (1 µM), apoptotic cell death was also prevented (Fig. 6a).

Cell death measured as LDH released in the first 30 min was completely counteracted when SOD and nimodipine were present during the 30-min depolarizing pulse, but not by CsA (Fig. 6b).

These results suggest that the amount of Ca2+ entering the cell with FPL64176, 30 mM K, 5 mM Ca2+ during 30 min, that corresponds to 496 ± 77 nM·s of [Ca2+]c, mediates early necrotic cell death (LDHe) and late apoptosis. Early necrotic cell death and late apoptosis could be prevented by nimodipine and SOD. Therefore, blockade of L-channels and superoxide radicals are involved both in early necrotic and late apoptotic cell death. The fact that CsA did not protect against early necrosis suggests that release of cytochrome c, under these experimental conditions, is primarily activating the apoptotic cascade and cell death at later stages.

Calcium Overload through L-type Ca2+ Channels Increases Mitochondrial [Ca2+], Mitochondrial Membrane Depolarization, and Release of Free Radicals-- Mitochondria are involved in Ca2+ sequestration during an excytotoxic insult (47). Recent studies have begun to clarify the deleterious effects that may result from mitochondrial Ca2+ overload. Rapid Ca2+ uptake causes mitochondrial depolarization (48), impairment of energy metabolism (49), and uncoupling of electron transport from ATP production (50, 51) and cell death.

With this background in mind, we carried out experiments to determine whether Ca2+ driven through L-type Ca2+ channels was being seen primarily by the mitochondria and if this Ca2+ was able to depolarize the mitochondrial membrane that, in turn, would lead to cell death. Fluorescence measurements of [Ca2+]c were performed in single loaded cells with Fura-2/AM. Fig. 7a shows an original trace of an experiment where two initial control (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+) depolarizing pulses (10 s) were applied, followed by a pulse in the presence of the protonophore CCCP (2 µM) or after pretreatment with CCCP for 20 s. In both cases, when Ca2+ uptake by mitochondria was prevented with CCCP, the [Ca2+]c signal almost doubled that of control pulses.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 7.   Mitochondria are buffering Ca2+ overload through L-channels. In a and b, cells were loaded with the fluorescent dye Fura-2/AM to monitor the [Ca2+]c. a shows two control depolarizations with 0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+ for 10 s. In the presence of the protonophore CCCP (2 µM), Ca2+ overload through L-channels increased [Ca2+]c 2-fold with respect to the control pulses. Pretreatment of the cell with CCCP for 10 s and CCCP plus the depolarizing pulse in the following 10-s pulse increased [Ca2+]c substantially, indicating the participation of mitochondria in [Ca2+]c buffering. The same protocol was followed in b, to test the calcium buffering capacity of the endoplasmic reticulum; the cell was superfused with caffeine (10 mM), ryanodine (10 µM), and thapsigargin (1 µM) for 3 min, previous to the depolarizing pulse, to deplete the endoplasmic reticulum Ca2+. Under these conditions, the [Ca2+]c was not modified.

A similar experimental procedure was carried out to test the contribution of the endoplasmic reticulum to the buffering of Ca2+ entering through L-type Ca2+ channels (Fig. 7b). After the application of two control pulses (0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+), the endoplasmic reticulum was depleted using the combination of 10 mM caffeine, 10 µM ryanodine, and 1 µM thapsigargin. The depolarizing pulse given in the presence of the endoplasmic reticulum-depleting solution did not increase the intracellular Ca2+ signal, indicating little or no contribution of the endoplasmic reticulum to the buffering of cytosolic Ca2+ in these experimental conditions. Therefore, these results suggest that mitochondria are the main buffering system for Ca2+ overload through L-channels.

In order to determine whether [Ca2+]c elevations mediated by activation of L-channels (FPL64176, 30 mM K+, 5 mM Ca2+) were able to depolarize the mitochondria, we measured the Delta Psi m with the fluorescent dye rhodamine 123. Confocal images were taken every 0.372 s. Fig. 8 shows experiments that illustrate how FPL64176, 30 mM K+, 5 mM Ca2+ induced increases in the fluorescence of rhodamine 123, indicating mitochondrial membrane depolarization; when the same cell was perfused with FPL, 30 mM K+, 5 mM Ca2+ in the presence of nimodipine, mitochondrial depolarization was prevented. These results demonstrate that depolarization of the mitochondrial membrane occurs when an elevation of [Ca2+]c occurs, in this case after the opening of L-type Ca2+ channels.


View larger version (44K):
[in this window]
[in a new window]
 
Fig. 8.   Ca2+ entry through L-channels depolarizes the mitochondrial membrane, an effect that could be prevented by nimodipine. After recording base-line fluorescence of rhodamine 123, the cells were exposed for 10 s to 0.3 µM FPL64176, 30 mM K+, 5 mM Ca2+; a direct depolarization of the mitochondria could be seen as an increase of fluorescence. After washout, the same cell was again stimulated with FPL64176, 30 mM K+, 5 mM Ca2+ in the presence of 1 µM nimodipine (added 2 min before), and the increase in fluorescence was completely abolished. The same set of stimuli were repeated in the same cell. b and c represent the sequential fluorescent images obtained in a confocal microscope of the first and second stimuli presented in a.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

We demonstrate in this study that sustained, mild K+ depolarization causes chromaffin cell death (Fig. 1b) through a Ca2+-dependent mechanism. Under these conditions, Ca2+ can gain the cell cytosol through several of the voltage-dependent Ca2+ channels described in bovine chromaffin cells. As indicated by numerous patch-clamp studies, external Ca2+ enters the voltage-clamped bovine chromaffin cell during depolarization through L-type (20%), N-type (30%), and P/Q-type (50%) Ca2+ channels (see Ref. 18). Despite this, it was curious that most of the Ca2+ entering through L-channels, but not through N- or P/Q-channels, was responsible for the activation of the death signal, as proven by the following observations. (i) The L-type Ca2+ channel activators Bay K 8644 and FPL64176 more than doubled the cytotoxic effects of 30 mM K+; (ii) the L-type Ca2+ channel blocker nimodipine suppressed the cytotoxic effects of 30 mM K+ alone or 30 mM K+ plus FPL64176; (iii) conversely, toxin blockade of N- and P/Q-channels caused partial cytoprotection at 0.2-2 mM [Ca2+]e and no protection at 5-20 mM [Ca2+]e; and (iv) the potentiation by FPL64176 of the K+-evoked [Ca2+]c elevation was suppressed by nimodipine.

The partial cytoprotection afforded by combined toxins at the lower [Ca2+]e is puzzling but can surely be interpreted in the context of the recent finding of our laboratory showing the Ca2+-dependent inactivation of L-, N-, and P/Q-channels in voltage-clamped bovine chromaffin cells (39). The elevation of [Ca2+]c elicited by the mitochondrial uncoupler CCCP during cell depolarization causes a faster inhibition of N- and P/Q-channels, as compared with L-channels. This might explain why, in the present study, Ca2+ entry through L-type Ca2+ channels caused greater cell lesion than that gained through N- and P/Q-channels. Despite the fact that L-channels account for only one-fifth of the total Ca2+ entering the cell during depolarization, they are capable of triggering a cell death signal with more efficacy than N- or P/Q-channels. Now the question arises as to how such Ca2+ entry through L-channels causes cell death.

Prolonged depolarization induced by K+ caused a transient sharp rise of [Ca2+]c followed by a sustained plateau. Although this bulk [Ca2+]c elevation reached only around 1 µM, it is certain that mitochondria see greater Ca2+ transients at subplasmalemmal sites near the Ca2+ channels; thus, using mitochondrially targeted aequorin, we have recently shown that Ca2+ inside the mitochondria can reach near millimolar concentrations during cell depolarization (52). If these elevations of [Ca2+]m are sustained, then the mitochondrial transition pore will open (49, 53, 54), and the apoptotic cascade will be activated. These findings suggest the following. (i) Cell exposure to K+ plus FPL64176 caused depolarization of mitochondria, surely due to mitochondrial Ca2+ accumulation; (ii) CsA, a blocker of the mitochondrial transition pore, prevented the apoptotic cell death induced by K+ plus FPL64176; (iii) and SOD also suppressed this apoptotic signal, suggesting that mitochondrial Ca2+ overload was generating free radicals to cause cell death (13, 55, 56).

It is interesting that nimodipine provided full protection against both necrotic and apoptotic cell death. This finding reinforces the view that nimodipine might have direct neuroprotectant effects on neurons subjected to an ischemic insult (14, 57) in addition to its well known cerebrovascular vasodilatory effects (58). The neuroprotectant actions of nimodipine in clinical trials performed in patients suffering a thrombotic stroke have proven difficult to demonstrate (59-61). However, in experimental animal models of cerebral ischemia, a clear nimodipine-induced neuroprotection has been shown (22, 62), which is in line with the results of the experiments shown here.

In conclusion, our data suggest that N- and P/Q-type Ca2+ channels, which suffer rapid Ca2+-dependent inhibition after cell depolarization, are unlikely to contribute to cell death upon a depolarizing stimulus. This observation is in line with previous data from our laboratory indicating that blockers of N- and P/Q-type Ca2+ channels did not protect against veratridine-induced cell death (64, 65). However, they disagree with the observation that N-type Ca2+ channel blockers afforded protection in a rat model of cerebral ischemia (15). In contrast, L-type channels that are localized preferentially at the neuronal soma (66) inactivate more slowly and are clearly associated with cell Ca2+ overload, mitochondria depolarization, generation of free radicals, and cell death. These data strengthen the view that Ca2+ entry through L-channels during a cerebral ischemic condition causing neuronal depolarization (67) might be a critical determinant of delayed death of neurons located in the penumbra area. Hence, dihydropyridine blockers of L-channels should have pronounced neuroprotectant actions if given with an adequate therapeutic window to stroke patients.

    ACKNOWLEDGEMENT

We thank A. Garcia for computer assistance.

    FOOTNOTES

* This work was supported in part by Dirección General de Investigación Científica y Técnica DGICYT Grants PM99-004 (to A. G. G.) and PM99-0006 (to M. G. L.) and "CAM Grupos Estratégicos del III PRICIT" (to A. G. G.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ Postdoctoral fellow of Fundación Teófilo Hernando.

Postdoctoral fellow of Comunidad Autónoma of Madrid, Spain.

§§ To whom correspondence should be addressed: Dept. de Farmacología, Facultad de Medicina, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, Madrid 28029, Spain. Tel.: 34-91-3975386; Fax: 34-91-3975397; E-mail: manuela.garcia@uam.es.

Published, JBC Papers in Press, August 10, 2001, DOI 10.1074/jbc.M102334200

    ABBREVIATIONS

The abbreviations used are: VDCC, voltage-dependent calcium channels; SOD, superoxide dismutase; LDH, lactate dehydrogenase; [Ca2+]c, cytosolic Ca2+ concentration; [Ca2+]m, mitochondrial Ca2+ concentration; Delta Psi m, mitochondrial transmembrane potential; LDHe, extracellular LDH; [K+]e and [Ca2+]e, external K+ and Ca2+ concentration, respectively.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Cheung, J. Y., Bonventre, J. V., Malis, C. D., and Leaf, A. (1986) N. Engl. J. Med. 314, 1670-1676[Medline] [Order article via Infotrieve]
2. Choi, D. W. (1995) Trends Neurosci. 18, 58-60[CrossRef][Medline] [Order article via Infotrieve]
3. Siesjö, B. K. (1981) Cereb. Blood Flow Metab. 1, 155-185[Medline] [Order article via Infotrieve]
4. Small, D. L., Monette, R., Buchan, A. M., and Morley, P. (1997) Brain Res. 753, 209-218[CrossRef][Medline] [Order article via Infotrieve]
5. Fern, R., Davis, P., Waxman, S. G., and Ransom, B. R. (1998) J. Neurophysiol. 79, 95-105[Abstract/Free Full Text]
6. Ueda, K., Shinohara, S., Yagami, T., Asakura, K., and Kawasaki, K. (1997) J. Neurochem. 68, 265-271[Medline] [Order article via Infotrieve]
7. Mattson, M. P., Cheng, B., Davis, D., Bryant, K., Lieberburg, I., and Rydel, R. E. (1992) J. Neurochem. 12, 376-389
8. Mattson, M. P., Barger, S. W., Cheng, B., Lieberburg, I., Smith-Swintosky, V. L., and Rydel, R. E. (1993a) Brain Res. 16, 409-415
9. Mattson, M. P., Tomaselli, K. J., and Rydel, R. E. (1993) Brain Res. 621, 35-49[CrossRef][Medline] [Order article via Infotrieve]
10. Goodman, Y., and Mattson, M. P. (1994) Exp. Neurol. 128, 1-12[CrossRef][Medline] [Order article via Infotrieve]
11. Goodman, Y., Steiner, M. R., Steiner, S. M., and Mattson, M. P. (1994b) Brain Res. 654, 171-176[CrossRef][Medline] [Order article via Infotrieve]
12. Keyser, D. J., Sulter, G., Langedijk, M., Elting, J. W., and Van der Naalt, J. (1999) Acta Clin. Belg. 54, 302-305[Medline] [Order article via Infotrieve]
13. Mason, R. P., Leeds, P. R., Jacob, R. F., Hough, C. J., Zhang, K. G., Mason, P. E., and Chuang, D. M. (1999) J. Neurochem. 72, 1448-1456[CrossRef][Medline] [Order article via Infotrieve]
14. Pisani, A., Calabresi, P., Tozzi, A., D'Angelo, V., and Bernardi, G. (1998) Stroke 29, 196-202[Abstract/Free Full Text]
15. Valentino, K., Newcomb, R., Gadbois, T., Singh, T., Bowersonx, S., Bitner, S., Justice, A., Yamashiro, D., Hoffman, B. B., Ciaranello, R., Miljanich, G., and Ramachandran, J. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 7894-7897[Abstract/Free Full Text]
16. Takahashi, T., and Momiyama, A. (1993) Nature 366, 156-158[CrossRef][Medline] [Order article via Infotrieve]
17. Olivera, B. M., Miljanich, G., Ramachandran, J., and Adams, M. E. (1994) Annu. Rev. Biochem. 63, 823-867[CrossRef][Medline] [Order article via Infotrieve]
18. García, A. G., Gandía, L., López, M. G., and Montiel, C. (2000) in Seafood and Freshwater Toxins: Pharmacology, Physiology, and Detection (Luis, M., ed) , pp. 99-124, Botana, New York
19. Hell, J. W., Westenbroek, R. E., Warner, C., Ahlijanian, M. K., Prystay, W., Gilbert, M. M., Snutch, T. H., and Catteral, W. A. (1993) J. Cell Biol. 123, 949-962[Abstract/Free Full Text]
20. Ahlijanian, M. K., Westenbroek, R. E., and Catterall, W. A. (1990) Neuron 4, 819-832[CrossRef][Medline] [Order article via Infotrieve]
21. Westebroek, R. E., Ahlijanian, M. K., and Catterall, W. A. (1990) Nature 347, 281-284[CrossRef][Medline] [Order article via Infotrieve]
22. Kobayashi, T., and Mori, Y. (1998) Eur. J. Pharmacol. 363, 1-15[CrossRef][Medline] [Order article via Infotrieve]
23. Koh, J. Y., and Cotman, C. W. (1992) Brain Res. 587, 233-240[CrossRef][Medline] [Order article via Infotrieve]
24. Leski, H. L., Stacey, L. V., and Coyle, J. T. (1999) Brain Res. 828, 27-40[CrossRef][Medline] [Order article via Infotrieve]
25. Albillos, A., García, A. G., Olivera, B. M., and Gandía, L. (1996) Pflügers Arch. Eur. J. Physiol. 432, 1030-1038[CrossRef][Medline] [Order article via Infotrieve]
26. Tsien, R. W., Ellinor, P. T., and Horne, W. A. (1991) Trends Pharmacol. Sci. 12, 349-354[CrossRef][Medline] [Order article via Infotrieve]
27. Albillos, A., Neher, E., and Moser, T. (2000) J. Neurosci. 20, 8323-8330[Abstract/Free Full Text]
28. Livett, B. G. (1984) Physiol. Rev. 64, 1103-1161[Free Full Text]
29. Moro, M. A., López, M. G., Gandía, L., Michelena, P., and García, A. G. (1990) Anal. Biochem. 185, 243-248[CrossRef][Medline] [Order article via Infotrieve]
30. Cano-Abad, M. F., López, M. G., Hernández-Guijo, J. M., Zapater, P., Gandía, L., Sánchez-García, P., and García, A. G. (1998) Br. J. Pharmacol. 124, 1187-1196[CrossRef][Medline] [Order article via Infotrieve]
31. Mark, R. J., Henesley, K., Butterfield, D. A., and Mattson, M. P. (1995) J. Neurosci. 15, 6239-6249[Abstract]
32. Kapila, Y. L., Wang, S., and Johnson, P. W. (1999) J. Biol. Chem. 274, 30906-30913[Abstract/Free Full Text]
33. Neher, E. (1989) in Neuromuscular Junction (Sellin, L. P. , Libelius, R. , and Thesleff, S., eds) , pp. 65-76, Elsevier, Amsterdam
34. Grynkiewicz, G., Poenie, M., and Tsien, R. Y. (1985) J. Biol. Chem. 260, 3440-3450[Abstract/Free Full Text]
35. Mattson, M. P., Zhang, Y., and Bose, S. (1993c) Exp. Neurol. 121, 1-13[CrossRef][Medline] [Order article via Infotrieve]
36. Krajeweski, S., Krajeweski, M., Ellerby, L. M., Welsh, K., Xie, Z., Deverausx, Q. L., Salvensen, G. S., Bredesen, D. E., Rosenthal, R. E., Fiskum, G., and Reed, J. C. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 5752-5757[Abstract/Free Full Text]
37. Grouselle, M., Tueux, O., Dabadie, P., Georgescand, D., and Mazat, J. P. (1990) Biochem. J. 271, 269-272[Medline] [Order article via Infotrieve]
38. Villarroya, M., Olivares, R., Ruiz, A., Cano-Abad, M., De Pascual, R., Lomax, R. B., López, M. G., and García, A. G. (1999) J. Physiol. 516, 421-432[Abstract/Free Full Text]
39. Henández-Guijo, J. M., Maneu-Flores, V. E., Ruiz-Nuño, A., Villarroya, M., García, A. G., and Gandía, L. (2001) J. Neurosci. 21, 2553-2560[Abstract/Free Full Text]
40. Michelena, P., García-Pérez, L. E., Artalejo, A. R., and García, A. G. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 3284-3288[Abstract/Free Full Text]
41. García, A. G., Sala, F., Reig, J. A., Viniegra, S., Frias, J., Fonteríz, R., and Gandía, L. (1984) Nature 309, 69-71[CrossRef][Medline] [Order article via Infotrieve]
42. Fonteríz, R. I., Gandía, L., López, M. G., Artalejo, C. R., and García, A. G. (1987) Brain Res. 408, 359-363[CrossRef][Medline] [Order article via Infotrieve]
43. Kruman, I. I., and Mattson, M. P. (1999) J. Neurochem. 72, 529-540[CrossRef][Medline] [Order article via Infotrieve]
44. Turrens, J. F., Alexander, A., and Lehninger, A. L. (1985) Arch. Biochem. Biophys. 237, 408-414[CrossRef][Medline] [Order article via Infotrieve]
45. Coyle, J. P., and Puttfarcken, P. (1993) Science 262, 689-696[Abstract/Free Full Text]
46. Szalai, G., Krishnamurthy, R., and Hajnoczky, G. (1999) EMBO J. 22, 6349-6361[CrossRef]
47. Griffiths, E. J., and Halestrap, A. P. (1995) Biochem. J. 307, 93-98
48. Schinder, A. F., Olsen, E. C., Spitzer, N. C., and Montal, M. (1996) J. Neurosci. 16, 6125-6133[Abstract/Free Full Text]
49. Duchen, M. R. (1999) J. Physiol. 516, 1-17[Abstract/Free Full Text]
50. Beatrice, M. C., Palmer, J. N., and Pfeiffer, D. R. (1980) J. Biol. Chem. 255, 86663-8671
51. Gunter, T. E., and Pleiffer, D. R. (1990) Am. J. Physiol. 258, C755-C786[Abstract/Free Full Text]
52. Montero, M., Alonso, M. T., Carnicero, E., Cuchillo, I., Albillos, A., García, A. G., García-Sancho, J., and Alvarez, J. (2000) Nat. Cell Biol. 2, 57-61[CrossRef][Medline] [Order article via Infotrieve]
53. Green, D. R., and Reed, J. C. (1998) Nature 281, 1309-1312
54. Hengartner, M. O. (2000) Nature 407, 770-776[CrossRef][Medline] [Order article via Infotrieve]
55. Carriedo, S. G., Yin, H. Z., Sensi, S. L., and Weiss, J. H. (1998) J. Neurosci. 18, 7727-7738[Abstract/Free Full Text]
56. Yuan, J., and Yankner, B. A. (2000) Nature 407, 802-808[CrossRef][Medline] [Order article via Infotrieve]
57. Ahmed, N., Nasman, P., and Wahlgren, N. G. (2000) Stroke 31, 1250-1255[Abstract/Free Full Text]
58. Allen, G. S., and Banghart, S. B. (1979) Neurosurgery 4, 37-42[Medline] [Order article via Infotrieve]
59. Mohr, J. P., Orgogozo, J. M., Harrison, M. J. G., Hennerici, M., Wahlgren, N. G., Gelmers, J. H., Matínez-Vila, E., Dycka, J., and Tetternborn, D. (1994) Cerebrovasc. Dis. 4, 197-203
60. Fogelholm, R., Erila, T., Palomaki, H., Murros, K., and Kaste, M. (2001) Cerebrovasc. Dis. 10, 189-193
61. Horn, J., de Haan, R. J., Vermeulen, M., and Limburg, M. (2001) Stroke 32, 461-465[Abstract/Free Full Text]
62. Hoffmesiter, F., Kazda, S., and Krause, H. P. (1979) Acta Neurol. Scand. 60, 358-359
63. Roda, J. M., Carceller, F., Diez-Tejedor, E., and Avendaño, C. (1995) Stroke 26, 1888-1892[Abstract/Free Full Text]
64. Maroto, R., de la Fuente, M. T., Artalejo, A. R., Abad, F., López, M. G., García-Sancho, J., and García, A. G. (1994) Eur. J. Pharmacol. 270, 331-339[CrossRef][Medline] [Order article via Infotrieve]
65. Maroto, R., de la Fuente, M. T., Zapater, P., Abad, F., Esquerro, E., and Garcia, A. G. (1996) Brain Res. 714, 209-214[CrossRef][Medline] [Order article via Infotrieve]
66. Murphy, T. H., Worley, P. F., and Baraban, J. M. (1991) Neuron 7, 625-635[CrossRef][Medline] [Order article via Infotrieve]
67. Blank, W. K., and Kirshner, H. S. (1977) Brain Res. 123, 113-124[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
A. G. Garcia, A. M. Garcia-De-Diego, L. Gandia, R. Borges, and J. Garcia-Sancho
Calcium signaling and exocytosis in adrenal chromaffin cells.
Physiol Rev, October 1, 2006; 86(4): 1093 - 1131.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
X. Chen, X. Zhang, H. Kubo, D. M. Harris, G. D. Mills, J. Moyer, R. Berretta, S. T. Potts, J. D. Marsh, and S. R. Houser
Ca2+ Influx-Induced Sarcoplasmic Reticulum Ca2+ Overload Causes Mitochondrial-Dependent Apoptosis in Ventricular Myocytes
Circ. Res., November 11, 2005; 97(10): 1009 - 1017.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
T. Tanaka, M. Nangaku, T. Miyata, R. Inagi, T. Ohse, J. R. Ingelfinger, and T. Fujita
Blockade of Calcium Influx through L-Type Calcium Channels Attenuates Mitochondrial Injury and Apoptosis in Hypoxic Renal Tubular Cells
J. Am. Soc. Nephrol., September 1, 2004; 15(9): 2320 - 2333.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/43/39695    most recent
M102334200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cano-Abad, M. F.
Right arrow Articles by López, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cano-Abad, M. F.
Right arrow Articles by López, M. G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement